Russia experiencing antidepressants sales boom this year

Sales of antidepressants in Russia during the period of January-February 2025 amounted to 2.8 billion roubles ($30 million) with a total of 3.2 million packages sold, which became a record figure for the country in the last five years, reports The Pharma Letter’s local correspondent.

According to the Russian analytical company DSM Group, that became by 30% higher than last year in value terms and by 15% in volume.

The analysts noted that, currently, Russia is experiencing a boom in demand for antidepressants, which has led to a sharp growth of their consumption and a switch of demand to more modern drugs in the upper price segment. In accordance with the official data, the biggest growth of sales was observed in case of duloxetine (+ 51% year-on-year), escitalopram (+ 30%) and sertraline (+ 35%).